Harousseau JL - Search Results

1

Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.

Moreau P, Robillard N, Avet-Loiseau H, Pineau D, Morineau N, Milpied N, Harousseau JL, Bataille R. Moreau P, et al. Among authors: harousseau jl. Haematologica. 2004 May;89(5):547-51. Haematologica. 2004. PMID: 15136217

2

Reactive plasmacytoses in multiple myeloma during hematopoietic recovery with G- or GM-CSF.

Jego G, Avet-Loiseau H, Robillard N, Moreau P, Amiot M, Harousseau J, Pellat-Deceunynck C, Bataille R. Jego G, et al. Leuk Res. 2000 Jul;24(7):627-30. doi: 10.1016/s0145-2126(00)00033-3. Leuk Res. 2000. PMID: 10867139

3

Long-term complications of total body irradiation in adults.

Thomas O, Mahé M, Campion L, Bourdin S, Milpied N, Brunet G, Lisbona A, Le Mevel A, Moreau P, Harousseau J, Cuillière J. Thomas O, et al. Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):125-31. doi: 10.1016/s0360-3016(00)01373-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11163505

4

Interferon alpha extends the survival of human myeloma cells through an upregulation of the Mcl-1 anti-apoptotic molecule.

Puthier D, Thabard W, Rapp M, Etrillard M, Harousseau J, Bataille R, Amiot M. Puthier D, et al. Br J Haematol. 2001 Feb;112(2):358-63. doi: 10.1046/j.1365-2141.2001.02575.x. Br J Haematol. 2001. PMID: 11167829 Free article.

5

Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial.

Moreau P, Facon T, Attal M, Hulin C, Michallet M, Maloisel F, Sotto JJ, Guilhot F, Marit G, Doyen C, Jaubert J, Fuzibet JG, François S, Benboubker L, Monconduit M, Voillat L, Macro M, Berthou C, Dorvaux V, Pignon B, Rio B, Matthes T, Casassus P, Caillot D, Najman N, Grosbois B, Bataille R, Harousseau JL; Intergroupe Francophone du Myélome. Moreau P, et al. Among authors: harousseau jl. Blood. 2002 Feb 1;99(3):731-5. doi: 10.1182/blood.v99.3.731. Blood. 2002. PMID: 11806971 Free article. Clinical Trial.

6

CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.

Chevallier P, Penther D, Avet-Loiseau H, Robillard N, Ifrah N, Mahé B, Hamidou M, Maisonneuve H, Moreau P, Jardel H, Harousseau JL, Bataille R, Garand R. Chevallier P, et al. Among authors: harousseau jl. Br J Haematol. 2002 Jan;116(1):142-50. doi: 10.1046/j.0007-1048.2001.3205.x. Br J Haematol. 2002. PMID: 11841407 Free article.

7

Tandem high-dose therapy followed by autologous stem-cell transplantation for refractory or relapsed high grade non-Hodgkin's lymphoma with poor prognosis factors: a prospective pilot study.

Le Gouill S, Moreau P, Morineau N, Harousseau JL, Milpied N. Le Gouill S, et al. Among authors: harousseau jl. Haematologica. 2002 Mar;87(3):333-4. Haematologica. 2002. PMID: 11869953

8

Oncogenesis of multiple myeloma: 14q32 and 13q chromosomal abnormalities are not randomly distributed, but correlate with natural history, immunological features, and clinical presentation.

Avet-Loiseau H, Facon T, Grosbois B, Magrangeas F, Rapp MJ, Harousseau JL, Minvielle S, Bataille R; Intergroupe Francophone du Myélome. Avet-Loiseau H, et al. Among authors: harousseau jl. Blood. 2002 Mar 15;99(6):2185-91. doi: 10.1182/blood.v99.6.2185. Blood. 2002. PMID: 11877296 Free article.

9

Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin.

Spisek R, Chevallier P, Morineau N, Milpied N, Avet-Loiseau H, Harousseau JL, Meflah K, Gregoire M. Spisek R, et al. Among authors: harousseau jl. Cancer Res. 2002 May 15;62(10):2861-8. Cancer Res. 2002. PMID: 12019165

10

Antisense strategy shows that Mcl-1 rather than Bcl-2 or Bcl-x(L) is an essential survival protein of human myeloma cells.

Derenne S, Monia B, Dean NM, Taylor JK, Rapp MJ, Harousseau JL, Bataille R, Amiot M. Derenne S, et al. Among authors: harousseau jl. Blood. 2002 Jul 1;100(1):194-9. doi: 10.1182/blood.v100.1.194. Blood. 2002. PMID: 12070027 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters